Fig. 4From: Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registryACR improvement rates over time. Improvement rates of disease activity parameters over the course of etanercept treatment according to the JIA-American College of Rheumatology (ACR) criteriaBack to article page